AngioDynamics Acquires Eximo Medical, Enhancing Portfolio with Groundbreaking Laser Technology

The medical device industry has witnessed a significant breakthrough with AngioDynamics' recent acquisition of Eximo Medical. This strategic move marks the integration of Eximo's proprietary laser technology into AngioDynamics' portfolio, further expanding its offerings in vascular treatments and therapies.

The Eximo laser technology boasts unparalleled precision, safety, and efficiency, setting it apart from traditional atherectomy devices. According to Jim Clemmer, President and CEO of AngioDynamics, the acquisition brings 'a remarkable, foundational technology' that will revolutionize the way caregivers deliver treatment to patients with Peripheral Artery Disease (PAD).

The transaction is funded exclusively through AngioDynamics' cash reserves, with $46 million in upfront consideration and up to an additional $20 million in contingent consideration. This significant investment underscores the company's commitment to advancing innovative medical solutions.

Eximo Medical's proprietary laser technology has received 510(k) clearance for use in PAD treatment, making it a valuable addition to AngioDynamics' product portfolio. The company's thrombus management and venous insufficiency technologies will now be complemented by Eximo's cutting-edge laser platform.

AngioDynamics' acquisition of Eximo Medical is expected to have a profound impact on the medical device industry. With its expanded offerings, the company is poised to make a meaningful difference in the lives of patients worldwide.

The acquisition reinforces AngioDynamics' position as a leading developer of innovative, minimally invasive medical devices for vascular diseases and oncology. Based in Latham, NY, the company's dedication to advancing healthcare solutions has led to this significant milestone.

As Eximo Medical's technology becomes an integral part of AngioDynamics' portfolio, it is clear that the partnership will drive positive change in the treatment of Peripheral Artery Disease. With its commitment to precision, safety, and efficiency, Eximo laser atherectomy is set to revolutionize the medical device landscape.